E3 PreliminaryPreliminaryPEM unclearReview-NarrativePeer-reviewedMachine draft
[Long COVID: nosographic aspects and clinical epidemiology].
Abrignani, Maurizio G, Maloberti, Alessandro, Temporelli, Pier Luigi et al. · Giornale italiano di cardiologia (2006) · 2022 · DOI
Quick Summary
Long COVID is a condition where people experience ongoing symptoms weeks or months after recovering from COVID-19 infection. Symptoms can include fatigue, difficulty thinking clearly, shortness of breath, muscle pain, sleep problems, and reduced ability to do daily activities. This review looks at how common long COVID is, who is most likely to develop it, and what we currently know about the condition.
Why It Matters
This review is relevant to ME/CFS research because long COVID and ME/CFS share several cardinal features, including post-exertional malaise, cognitive dysfunction, and fatigue that restrict functional capacity. Understanding long COVID's epidemiology and clinical presentation may provide insights into post-viral conditions more broadly and could inform case definitions and study design for both conditions.
Observed Findings
- Long COVID symptoms emerge 4-12 weeks after acute SARS-CoV-2 infection in a subset of recovered patients.
- Symptoms are multisystemic and heterogeneous, including fatigue, post-exertional malaise, dyspnea, cognitive impairment, sleep disturbance, anxiety, depression, muscle pain, brain fog, anosmia/dysgeusia, and headache.
- Female sex, initial disease severity, and comorbidities are identified as risk factors for developing long COVID.
- Long COVID affects patients across the full spectrum of acute COVID-19 severity, from mild to severe.
Inferred Conclusions
- Clinical heterogeneity and lack of shared case definitions prevent accurate determination of long COVID's true prevalence and incidence.
- Long COVID represents a significant, ongoing public health concern requiring better characterization and understanding of potential sequelae.
- Standardized definitions and epidemiological frameworks are necessary to advance long COVID research and clinical management.
Remaining Questions
- What are the mechanistic pathways underlying long COVID's multisystemic symptoms?
- How do long COVID symptom clusters relate to distinct pathophysiological endotypes?
- What are the precise prevalence and incidence rates once standardized case definitions are established?
What This Study Does Not Prove
As an editorial review rather than primary research, this study does not present original data or prove causal mechanisms underlying long COVID's symptoms. It does not establish the relationship between long COVID and ME/CFS, nor does it definitively establish prevalence rates, since it acknowledges that heterogeneous definitions prevent accurate epidemiological measurement.
Tags
Symptom:Post-Exertional MalaiseCognitive DysfunctionUnrefreshing SleepPainFatigueSensory Sensitivity
Phenotype:Infection-TriggeredLong COVID Overlap
Method Flag:PEM Not DefinedWeak Case DefinitionExploratory Only
Metadata
- DOI
- 10.1714/3860.38447
- PMID
- 36039714
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →